About Joshua McClure
Form D filings for Maxwell Biosciences from 2022 to 2023 list Joshua McClure as president and CEO, director.
Joshua McClure first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Joshua McClure in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joshua McClure works with at each company, as listed on that company's latest Form D.
Maxwell Biosciences, Inc. · Form D, Jul 14, 2023